QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
NASDAQ:SHPG

Shire (SHPG) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$179.20
▼
$179.20
50-Day Range
$179.20
▼
$179.20
52-Week Range
$123.73
▼
$182.47
Volume
N/A
Average Volume
2.21 million shs
Market Capitalization
$54.71 billion
P/E Ratio
11.83
Dividend Yield
0.19%
Price Target
N/A
ProfileFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media

SHPG stock logo

About Shire (NASDAQ:SHPG) Stock

Shire plc, a biotechnology company, researches, develops, licenses, manufactures, markets, distributes, and sells medicines for rare diseases and other specialized conditions worldwide. The company offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology. Its marketed products include ADVATE, ADYNOVATE/ADYNOVI, and OBIZUR for the treatment of hemophilia A; RIXUBIS to treat hemophilia B; VONVENDI for the treatment of von willebrand disease; FEIBA to treat hemophilia A and B patients with inhibitors; ELAPRASE to treat hunter syndrome; REPLAGAL for fabry disease; and VPRIV to treat type 1 Gaucher disease. The company's marketed products also comprise VYVANSE/VENVANSE/ELVANSE/TYVENSE/VUXEN/ADUVANZ for the treatment of attention deficit/hyperactivity disorder (ADHD) and binge eating disorder; ADDERALL XR and MYDAYIS to treat ADHD; GAMMAGARD LIQUID/KIOVIG, GAMMAGARD S/D, HYQVIA, and CUVITRU for the treatment of primary immunodeficiency; and FLEXBUMIN to treat hypovolemia and hypoalbuminemia. In addition, its marketed products consists of CINRYZE and FIRAZYR for the treatment of hereditary angioedema; FOSRENOL to treat hyperphosphatemia; LIALDA/MEZAVANT and PENTASA for ulcerative colitis; GATTEX/REVESTIVE for the treatment of short bowel syndrome; NATPARA for the control of hypocalcemia in patients with hypoparathyroidism; ONCASPAR to treat acute lymphoblastic leukemia; ONYVIDE for metastatic adenocarcinoma of the pancreas; and XIIDRA for the treatment of dry eye disease. The company markets its products through wholesalers, distributors, and pharmacies. It has collaborative and other licensing arrangements with Rani Therapeutics LLC; Parion Sciences Inc.; Pfizer Inc.; Precision BioSciences Inc.; Symphogen; and Ipsen Bioscience Inc., as well as a preclinical research collaboration agreement with NanoMedSyn. The company was founded in 1986 and is headquartered in Dublin, Ireland.

Receive SHPG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shire and its competitors with MarketBeat's FREE daily newsletter.

SHPG Stock News Headlines

March 30, 2023 | thestreet.com
Shire Stock Hits New 52-Week High (SHPG)
October 19, 2022 | bbc.com
Ethiopia's Tigray conflict: Nasa shows how a war zone faded from space - BBC
June 5, 2023 | Behind the Markets (Ad)
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
October 18, 2022 | bbc.com
Ethiopia civil war: Hyenas scavenge on corpses as Tigray forces retreat - BBC
October 18, 2022 | news.yahoo.com
Ethiopia civil war: Federal army seizes strategic city of Shire - Yahoo News
October 17, 2022 | washingtonpost.com
Ethiopian war in Tigray intensifies as government soldiers capture strategic Shire - The Washington Post
September 25, 2022 | dailymail.co.uk
Mum saves toddler with CPR in Sydney's Hills Shire: Triple-0 call revealed: Police Defibrillators - Daily Mail
September 15, 2022 | cbsnews.com
"Hobbit home" up for sale in River Falls, Wisconsin - CBS News
June 5, 2023 | Behind the Markets (Ad)
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
September 10, 2022 | npr.org
Fresh Air Weekend: Tennis great John McEnroe; Musician Amanda Shires - NPR
September 10, 2022 | npr.org
Best Of: John McEnroe / Amanda Shires : Fresh Air - NPR
September 7, 2022 | npr.org
Amanda Shires : Fresh Air - NPR
September 5, 2022 | theguardian.com
MLB’s Art Shires: hitter, peacock, boaster, boxer and accused killer - The Guardian
September 1, 2022 | countrystandardtime.com
Amanda Shires - Take It Like A Man - Country Standard Time
August 10, 2022 | theguardian.com
Dreaming shires: how East Yorkshire shaped Tolkien’s Middle-earth fantasy - The Guardian
August 3, 2022 | npr.org
On 'Take It Like a Man,' Amanda Shires takes aim for the heavens - NPR
July 29, 2022 | theguardian.com
Amanda Shires: Take It Like a Man review – reimagining country strong - The Guardian
July 21, 2022 | nytimes.com
Amanda Shires Isn’t Letting Nashville, or Her Marriage, Off the Hook - The New York Times
July 18, 2022 | dailymail.co.uk
Cat ban in Australia: Bass Coast Shire near Melbourne to fine pet owners if feline is outdoors - Daily Mail
July 17, 2022 | dailymail.co.uk
Nathan Brown lists $1.62million waterfront home in Sydney for sale - Daily Mail
June 23, 2022 | yahoo.com
Country singer Amanda Shires explains why she told her abortion story: 'It's part of my character to speak up' - Yahoo Life
June 17, 2022 | dallasnews.com
Richardson retail and office center is latest commercial property sale - The Dallas Morning News
May 26, 2022 | dailymail.co.uk
'Flood refugee' races to spruce up Scott Morrison's Shire home as he leaves Kirriblli House - Daily Mail
May 10, 2022 | bizjournals.com
Ignite Entertainment opens Shires' Cafe downtown at City Club Apartments - Cincinnati Business Courier - The Business Journals
April 26, 2022 | law360.com
2nd Circ. Affirms Shire Sanctions In Pharma IP Fight - Law360
April 11, 2022 | afr.com
Sydney property: “There's money in the shire, it's crazy”, says agent who just sold a Cronulla home with no water views for $4.9 million - The Australian Financial Review
March 29, 2022 | bbc.com
Shire Hall: Council to permanently protect land's public access - BBC.com
See More Headlines


SHPG Company Calendar

Last Earnings
4/26/2018
Today
6/05/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SHPG
CUSIP
N/A
CIK
936402
Web
www.shire.com
Phone
353-1609-6000
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
$15.15
Trailing P/E Ratio
11.83
Forward P/E Ratio
11.88
P/E Growth
1.54
Net Income
$4.27 billion
Net Margins
30.63%
Pretax Margin
N/A
Return on Equity
12.70%
Return on Assets
7.06%

Debt

Debt-to-Equity Ratio
0.36
Current Ratio
0.92
Quick Ratio
0.51

Sales & Book Value

Annual Sales
$15.16 billion
Price / Sales
3.61
Cash Flow
$22.71 per share
Price / Cash Flow
7.89
Book Value
$119.43 per share
Price / Book
1.50

Miscellaneous

Outstanding Shares
305,280,000
Free Float
N/A
Market Cap
$54.71 billion
Optionable
Optionable
Beta
0.87

Key Executives

  • Dr. Flemming Ornskov M.P.H.Dr. Flemming Ornskov M.P.H. (Age 60)
    MBA, M.D., MPH, CEO, MD & Exec. Director
  • Mr. Thomas J. W. Dittrich (Age 54)
    CFO & Director
  • Gisele Dion
    Chief Accounting Officer
  • Mr. Matthew Walker (Age 54)
    Head of Technical Operations
  • Dr. Andreas Busch Ph.D. (Age 55)
    Head of R&D and Chief Scientific Officer

Key Competitors

View All Competitors













SHPG Stock - Frequently Asked Questions

How were Shire's earnings last quarter?

Shire plc (NASDAQ:SHPG) issued its quarterly earnings results on Thursday, April, 26th. The biopharmaceutical company reported $3.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.58 by $0.28. The biopharmaceutical company earned $3.77 billion during the quarter. Shire had a trailing twelve-month return on equity of 12.70% and a net margin of 30.63%. The company's revenue for the quarter was up 5.4% on a year-over-year basis. During the same period last year, the firm earned $3.63 EPS.

Is Shire a good dividend stock?

Shire (NASDAQ:SHPG) pays an annual dividend of $0.34 per share and currently has a dividend yield of 0.19%. The dividend payout ratio is 2.24%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, SHPG will have a dividend payout ratio of 2.15% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for SHPG.

What other stocks do shareholders of Shire own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Shire investors own include Gilead Sciences (GILD), Intel (INTC), Merck & Co., Inc. (MRK), Cisco Systems (CSCO), Walt Disney (DIS), Johnson & Johnson (JNJ), Pfizer (PFE), Starbucks (SBUX) and Exxon Mobil (XOM).

What is Shire's stock symbol?

Shire trades on the NASDAQ under the ticker symbol "SHPG."

What is Shire's stock price today?

One share of SHPG stock can currently be purchased for approximately $179.20.

How much money does Shire make?

Shire (NASDAQ:SHPG) has a market capitalization of $54.71 billion and generates $15.16 billion in revenue each year. The biopharmaceutical company earns $4.27 billion in net income (profit) each year or $15.15 on an earnings per share basis.

How can I contact Shire?

Shire's mailing address is BLOCK 2 MIESIAN PLAZA 50-58 BAGGOT STREET LOWER, Dublin L2, D02. The official website for the company is www.shire.com. The biopharmaceutical company can be reached via phone at 353-1609-6000 or via email at rcoates@shire.com.

This page (NASDAQ:SHPG) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -